Kamada Ltd. (KMDA)
NASDAQ: KMDA · Real-Time Price · USD
7.23
+0.17 (2.42%)
Sep 5, 2025, 2:51 PM - Market open
Kamada Market Cap
Kamada has a market cap or net worth of $403.19 million as of September 5, 2025. Its market cap has increased by 23.60% in one year.
Market Cap
403.19M
Enterprise Value
348.43M
1-Year Change
23.60%
Ranking
Category
Stock Price
$7.23
Market Cap Chart
Since May 31, 2013, Kamada's market cap has increased from $346.50M to $403.19M, an increase of 16.36%. That is a compound annual growth rate of 1.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2025 | 406.00M | 15.97% |
| Dec 31, 2024 | 350.10M | 27.59% |
| Dec 29, 2023 | 274.40M | 52.78% |
| Dec 30, 2022 | 179.60M | -38.99% |
| Dec 31, 2021 | 294.40M | 12.58% |
| Dec 31, 2020 | 261.50M | -4.98% |
| Dec 31, 2019 | 275.20M | 36.71% |
| Dec 31, 2018 | 201.30M | 16.29% |
| Dec 29, 2017 | 173.10M | -12.80% |
| Dec 30, 2016 | 198.50M | 33.04% |
| Dec 31, 2015 | 149.20M | 9.22% |
| Dec 31, 2014 | 136.60M | -73.22% |
| Dec 31, 2013 | 510.10M | 47.22% |
| May 31, 2013 | 346.50M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 666.94B |
| Johnson & Johnson | 430.51B |
| AbbVie | 376.28B |
| UnitedHealth Group | 281.10B |
| AstraZeneca | 253.90B |
| Novo Nordisk | 249.80B |
| Novartis AG | 249.52B |
| Abbott Laboratories | 231.15B |